Literature DB >> 2868453

[Endocrine pancreatic tumor secreting somatostatin and somatocrinin].

D Chadenas, D Pinsard, D Melliere, J Trouillas, E S Zafrani, L Pradayrol, G Sassolas, Y Li, C Girod, J Aumaitre.   

Abstract

A case of endocrine pancreatic tumour secreting the 2 antagonistic peptides that regulate growth hormone, somatostatin and somatocrinin, is reported. Such tumours are extremely rare and only one other case has been published so far, although pancreatic malignant tumours frequently secrete several hormones. In our patient, the association of diabetes with steatorrhoea, hypochlorhydria, anaemia and biliary lithiasis suggested hypersecretion of somatostatin. Acromegaly, suggested by clinical signs, was confirmed by an excess of growth hormone and somatomedin, and pre-operative somatrocrinin assay confirmed its extra-pituitary origin. Finally, the presence of hyperparathyroidism due to parathyroid gland hyperplasia and of a Recklinghausen disease constituted a multiple endocrine neoplasia syndrome. The significance and implications of this double secretion in vivo are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868453

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Acromegaly secondary to growth hormone releasing hormone secretion.

Authors:  L Farrell; P Downey; P Keeling; E Leen; S Sreenan
Journal:  Ir J Med Sci       Date:  2004 Oct-Dec       Impact factor: 1.568

2.  Pancreatic polypeptide in somatostatinoma.

Authors:  D Pinsard; S Odent; D Chadenas
Journal:  Dig Dis Sci       Date:  1986-04       Impact factor: 3.199

Review 3.  Ectopic secretion of growth hormone-releasing hormone in man.

Authors:  M Losa; J Schopohl; K von Werder
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

4.  Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.

Authors:  Nienke R Biermasz; Jan W A Smit; Alberto M Pereira; Marijke Frölich; Johannes A Romijn; Ferdinand Roelfsema
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.